9M 2022/23 Interim financial results, 9M 2022/23 1 October 2022 - 30 June 2023 Coloplast delivered Q3 organic growth of 8% and 28% EBIT margin 1) . Reported revenue in DKK grew 4% to 6,108 million Organic growth rates by business area: Ostomy Care 8%, Continence Care 9%, Voice and Respiratory Care 9%, Wound and Skin Care 4% (Wound Care 5%), and Interventional Urology 7%. Continued good momentum across regions in Chronic Care. China Ostomy Care posted double-digit growth, reflecting a lower...